American Realty Capital Healthcare Trust, Inc. (NASDAQ:HCT) Investor Investigation Over Potential Breaches Of Fidcuiary Duties In buyout Announced

If you purchased shares of American Realty Capital Healthcare Trust, Inc. (NASDAQ:HCT) and currently hold any of those NASDAQ:HCT shares, you have certain options and you should contact the Shareholders Foundation, Inc.

To have your information reviewed for options and to recieve notifications about this investigation, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.
Company Name(s): 
American Realty Capital Healthcare Trust
Affected Securities: 
NASDAQ: HCT

June 10, 2014 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of American Realty Capital Healthcare Trust, Inc. (NASDAQ:HCT) shares, was announced concerning whether the takeover of American Realty Capital Healthcare Trust, Inc. by Ventas, Inc is unfair to (NASDAQ:HCT stockholders.

The investigation by a law firm concerns whether certain officers and directors of American Realty Capital Healthcare Trust breached their fiduciary duties owed to NASDAQ:HCT investors in connection with the proposed acquisition.

On June 2, 2014, Ventas, Inc. (NYSE: VTR) and American Realty Capital Healthcare Trust, Inc. (NASDAQ: HCT) announced that the Boards of Directors of both companies have approved an agreement under which Ventas will acquire all of the outstanding shares of American Realty Capital Healthcare Trust, Inc. in a stock and cash transaction valued at $2.6 billion, or $11.33 per American Realty Capital Healthcare Trust, Inc. share.

However, the investigation concerns whether the offer is unfair to NASDAQ:HCT stockholders. More specifically, the investigation concerns whether the American Realty Capital Healthcare Trust Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.